Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. [electronic resource]
- Future oncology (London, England) Mar 2018
- 527-536 p. digital
Publication Type: Journal Article
1744-8301
10.2217/fon-2017-0438 doi
Aged Aged, 80 and over Comorbidity Cost of Illness Humans Male Middle Aged Prostatic Neoplasms, Castration-Resistant--diagnosis Public Health Surveillance Quality of Life Registries Risk Factors Socioeconomic Factors United States--epidemiology